Belpointe Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Belpointe Asset Management's RPRX Position: Q2 2026 in Review
Belpointe Asset Management opened a new position in Royalty Pharma (RPRX) in Q2 2026: 5,485 shares worth $308K. The stake represents 0.01% of the portfolio and ranks #891 among its holdings. This is a return to the name: Belpointe Asset Management previously reported a position in RPRX as recently as Q2 2025.
Belpointe Asset Management first reported a position in RPRX in Q4 2022 and has held it in 4 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Belpointe Asset Management held 5,485 shares of Royalty Pharma worth $308K as of Q2 2026.
- Royalty Pharma was a new Belpointe Asset Management position in Q2 2026.
- Royalty Pharma made up 0.01% of Belpointe Asset Management's portfolio in Q2 2026, its #891 holding.
- Belpointe Asset Management first reported a position in Royalty Pharma in Q4 2022 and has held it in 4 quarters since.
- 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.